These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9134004)

  • 1. Primary chemotherapy for early breast cancer.
    Ellis PA; Smith IE
    Cancer Treat Rev; 1996 Nov; 22(6):437-50. PubMed ID: 9134004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary chemotherapy in operable breast carcinoma].
    Bonadonna G; Valagussa P
    Ann Ital Chir; 1999; 70(3):359-69. PubMed ID: 10466239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary systemic therapy in operable breast cancer.
    Wolff AC; Davidson NE
    J Clin Oncol; 2000 Apr; 18(7):1558-69. PubMed ID: 10735905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary chemotherapy in breast cancer.
    Smith IE; al-Moundhri M
    Biomed Pharmacother; 1998; 52(3):116-21. PubMed ID: 9755804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant systemic therapy for breast cancer: an overview and review of recent clinical trials.
    Hanrahan EO; Hennessy BT; Valero V
    Expert Opin Pharmacother; 2005 Aug; 6(9):1477-91. PubMed ID: 16086636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer.
    Franceschini G; Di Leone A; Natale M; Sanchez MA; Masett R
    Ann Ital Chir; 2018; 89():290. PubMed ID: 30352955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer chemotherapy.
    McArthur HL; Hudis CA
    Cancer J; 2007; 13(3):141-7. PubMed ID: 17620762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
    Goble S; Bear HD
    Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy for breast cancer.
    Sapunar F; Smith IE
    Ann Med; 2000 Feb; 32(1):43-50. PubMed ID: 10711577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary chemotherapy in surgically resectable breast cancer.
    Bonadonna G; Valagussa P; Zucali R; Salvadori B
    CA Cancer J Clin; 1995; 45(4):227-43. PubMed ID: 7600279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?
    Freedman OC; Verma S; Clemons MJ
    Cancer Treat Rev; 2005 Feb; 31(1):1-17. PubMed ID: 15707700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient benefits from new treatment options and schedules for breast cancer.
    Smith IE
    Semin Oncol; 1997 Aug; 24(4 Suppl 10):S10-22-S10-26. PubMed ID: 9275003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of primary chemotherapy in early breast cancer.
    Harris L; Swain SM
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):31-42. PubMed ID: 8614843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and future roles of neoadjuvant chemotherapy in operable breast cancer.
    Kim R; Osaki A; Toge T
    Clin Breast Cancer; 2005 Aug; 6(3):223-32; discussion 233-4. PubMed ID: 16137432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-agent chemotherapy for early breast cancer.
    Early Breast Cancer Trialists' Collaborative Group
    Cochrane Database Syst Rev; 2002; (1):CD000487. PubMed ID: 11869577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pitfall in the survival benefit of adjuvant chemotherapy for node- and hormone receptor-positive patients with breast cancer: the paradoxical role of Bcl-2 oncoprotein (review).
    Kim R; Osaki A; Toge T
    Int J Oncol; 2001 Nov; 19(5):1075-80. PubMed ID: 11605012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Herceptin in primary breast cancer: views from North America and Europe.
    Leyland-Jones B; Smith I
    Oncology; 2001; 61 Suppl 2():83-91. PubMed ID: 11694792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer.
    Bearman SI; Shpall EJ; Jones RB; Cagnoni PJ; Ross M
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):60-7. PubMed ID: 8614848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a standard type and duration of adjuvant chemotherapy for early stage breast cancer?
    Hayes DF
    Breast; 2009 Oct; 18 Suppl 3():S131-4. PubMed ID: 19914531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.